The immunogenicity and reactogenicity of the trivalent vaccine, Trimovax, indicated for prevention of measles, mumps, and rubella, in 12-month-old children in Belarus.

Authors

E O. Samoilovich
L A. Kapustik
E V. Feldman
M A. Yermolovich
A J. Svirchevskaya
D F. Zakharenko
Mary A. Fletcher, Nova Southeastern UniversityFollow
L P. Titov

Publication Title

Central European journal of public health

ISSN

1210-7778

Publication Date

8-1-2000

Volume

8

Issue

3

First Page

160

Last Page

3

Disciplines

Medical Specialties | Medicine and Health Sciences | Osteopathic Medicine and Osteopathy

NSUWorks Citation

Samoilovich, E O.; Kapustik, L A.; Feldman, E V.; Yermolovich, M A.; Svirchevskaya, A J.; Zakharenko, D F.; Fletcher, Mary A.; and Titov, L P., "The immunogenicity and reactogenicity of the trivalent vaccine, Trimovax, indicated for prevention of measles, mumps, and rubella, in 12-month-old children in Belarus." (2000). Faculty Articles. 1362.
https://nsuworks.nova.edu/hpd_com_faculty_articles/1362